Drivers of AR indifferent anti-androgen resistance in prostate cancer cells

Inhibition of the androgen receptor (AR) by second-generation anti-androgens is a standard treatment for metastatic castration resistant prostate cancer (mCRPC), but it inevitably leads to the development of resistance. Since the introduction of highly efficient AR signalling inhibitors, approximate...

Descripción completa

Detalles Bibliográficos
Autores principales: Handle, Florian, Prekovic, Stefan, Helsen, Christine, Van den Broeck, Thomas, Smeets, Elien, Moris, Lisa, Eerlings, Roy, Kharraz, Sarah El, Urbanucci, Alfonso, Mills, Ian G., Joniau, Steven, Attard, Gerhardt, Claessens, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760229/
https://www.ncbi.nlm.nih.gov/pubmed/31551480
http://dx.doi.org/10.1038/s41598-019-50220-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760229/
https://www.ncbi.nlm.nih.gov/pubmed/31551480
http://dx.doi.org/10.1038/s41598-019-50220-1

Ejemplares similares